Latest updates for Rhhby
Fresh curated links around RHHBY are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Going Deeper On Disc Medicine
- Analyst Report: Roche Holding AG
- Market Update: NLY, BRO, SANM, SLB, RHHBY, BKR
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
pharmexec.com
/1 week ago
<![CDATA[Henlius Enters $322 Million Strategic Collaboration with Sandoz ]]>
seekingalpha.com
/2 days ago
SA Asks: What are the most promising oncology companies right now?
finance.yahoo.com
/1 month ago
Pfizer Inc. (PFE): A Top Dividend Stock to Buy According to Hedge Funds amid Ibrance FDA Milestone
seekingalpha.com
/1 month ago
BridgeBio: "Strong Buy" Attruby Differentiation And Several NDA Submissions In Play
cafepharma.com
/1 month ago
Hoechst-Roussel
Hoechst-Roussel Anonymous (not verified) Thu, 07/16/2026 - 12:16 field_thread_url https://cafepharma.com/boards/threads/hoechst-roussel.12347/...
seekingalpha.com
/1 month ago
Hutchmed: Bullish On Their Commercial Prospects And Pipeline Catalysts
finance.yahoo.com
/1 week ago
Could AbbVie Inc. (ABBV)’s Post-Humira Transformation Drive the Next Phase of Growth?
seekingalpha.com
/1 month ago
Helus Pharma: APPROACHing Inflection: Pivotal Readout Sets Up Asymmetric Upside
biopharmadive.com
/1 month ago
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
J&J’s shares ticked down as oncology sales missed expectations. Elsewhere, AstraZeneca bet $600 million on a lung cancer drug and a pair of biotechs snagged two of the year’s t...
seekingalpha.com
/1 month ago
Merck: 'Strong Buy' Lipfendra FDA First And Continued Oncology Expansions
pharmexec.com
/1 week ago
<![CDATA[Pharmaceutical Executive Daily: Henlius and Sandoz Strike Collaboration Agreement]]>
seekingalpha.com
/1 month ago
Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions
tradebrains.in
/1 month ago
Multibagger Ashish Kacholia Stock in Which DIIs Nearly Tripled Their Stake to Keep on Your Radar
Synopsis: Institutional investors nearly tripled their stake in a Himachal Pradesh-based oncology pharma company in a single quarter, even as the stock rallied sharply – a vote of...
qchron.com
/4 days ago
Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026
iknowfirst.com
/1 month ago
Top Pharma Stocks Based on Artificial Intelligence: Returns up to 24.56% in 7 Days
Package Name: Pharma Stocks Forecast Recommended Positions: Long Forecast Length: 7 Days (7/1/26 - 7/8/26) I Know First Average: 4.47% Read The Full Forecast...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Rhhby
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
iknowfirst.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source